ABATE KRISTIN (Chief Accounting Officer) sold 0.1% of their position (19.00 shares) of KARYOPHARM THERAPEUTICS INC. on the open market
Open‑market sale worth $38.38 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/2/2026ACC: 0001193125-26-380404
Officer· Chief Accounting Officer
Since Mar 2026
-19.00
Net shares
Net seller
$38.38
Total sold
1
Open market trades
0B · 1S
1
Total transactions
19.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−19.00
Price / share
$2.02
Trade value
$38.38
% of position
0.1%
9/1/2026
23.80K→23.78K
Total
Net shares
−19.00
Net value
-$38.38
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | S · Sale | −19.00 | $2.02 | $38.38 | 0.1% | 23.80K | 23.78K |
| Total | −19.00 | -$38.38 | ||||||
Derivative Transactions0
No derivative transactions reported